TrialTransplantation and cellular therapy2021

Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis.

Masumi Ueda Oshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.